If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Basaglar ® (insulin glargine injection)
100 units/mLThis information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Basaglar is a long-acting human insulin analog indicated to improve glycemic control in
adults and pediatric patients with T1DM, and
adults with T2DM.1
Enclosed Prescribing Information
BASAGLAR® (insulin glargine injection), for subcutaneous use, Lilly
1. Basaglar [package insert]. Indianapolis, IN: Eli Lilly and Company; 2018.
Glossary
Basaglar = Basaglar® (insulin glargine injection) 100 units/mL
T1DM = type 1 diabetes mellitus
T2DM = type 2 diabetes mellitus
Date of Last Review: August 05, 2019
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 9am - 7pm EST